Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Eli Lilly
LLY
|
$4.12B |
| 2 |
NVIDIA
NVDA
|
$3.51B |
| 3 |
Starbucks
SBUX
|
$2.92B |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$1.99B |
| 5 |
UnitedHealth
UNH
|
$1.5B |
Top Sells
| 1 |
Apple
AAPL
|
$5.28B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$2.8B |
| 3 |
GE Aerospace
GE
|
$1.6B |
| 4 |
Meta Platforms (Facebook)
META
|
$1.49B |
| 5 |
PNC Financial Services
PNC
|
$1.34B |
Sector Composition
| 1 | Technology | 23.87% |
| 2 | Healthcare | 17.77% |
| 3 | Consumer Discretionary | 12.84% |
| 4 | Industrials | 11.65% |
| 5 | Financials | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mercado Libre
MELI
$125B
| $4.34B | 0.94% | 2,224,151 -191,664 | -8% | -$374M |
|
27
Linde
LIN
$224B
| $4.29B | 0.93% | 9,216,453 +2,163 | +0% | +$1.01M |
|
28
Netflix
NFLX
$513B
| $4.22B | 0.92% | 4,528,909 -441,946 | -9% | -$412M |
|
29
GE HealthCare
GEHC
$33.7B
| $4.13B | 0.9% | 51,195,068 -9,636,936 | -16% | -$778M |
|
30
Exxon Mobil
XOM
$487B
| $4.05B | 0.88% | 34,081,428 -681,751 | -2% | -$81.1M |
|
31
Air Products & Chemicals
APD
$65.5B
| $4.01B | 0.87% | 13,596,747 +283,324 | +2% | +$83.6M |
|
32
EOG Resources
EOG
$68.2B
| $3.82B | 0.83% | 29,754,893 -35,510 | -0.1% | -$4.55M |
|
33
Thermo Fisher Scientific
TMO
$186B
| $3.79B | 0.82% | 7,612,797 -307,929 | -4% | -$153M |
|
34
Medtronic
MDT
$119B
| $3.74B | 0.81% | 41,567,616 +8,363,931 | +25% | +$752M |
|
|
35
Starbucks
SBUX
$100B
| $3.47B | 0.76% | 35,422,093 +29,731,895 | +523% | +$2.92B |
|
36
Texas Instruments
TXN
$184B
| $3.35B | 0.73% | 18,637,526 -4,340,539 | -19% | -$780M |
|
37
Blackrock
BLK
$175B
| $3.25B | 0.71% | 3,432,383 +176,895 | +5% | +$167M |
|
38
Canadian Natural Resources
CNQ
$65.9B
| $3.08B | 0.67% | 100,040,568 +3,271,464 | +3% | +$101M |
|
39
Accenture
ACN
$162B
| $2.92B | 0.63% | 9,350,813 -2,944,935 | -24% | -$919M |
|
40
Chubb
CB
$110B
| $2.81B | 0.61% | 9,300,934 +406,971 | +5% | +$123M |
|
41
McDonald's
MCD
$224B
| $2.73B | 0.59% | 8,740,584 -1,911,861 | -18% | -$597M |
|
42
Nu Holdings
NU
$71.5B
| $2.7B | 0.59% | 264,058,454 +25,183,680 | +11% | +$258M |
|
43
Oracle
ORCL
$635B
| $2.66B | 0.58% | 19,010,522 +7,055,779 | +59% | +$986M |
|
44
DTE Energy
DTE
$28.4B
| $2.57B | 0.56% | 18,612,465 -256,963 | -1% | -$35.5M |
|
45
Stryker
SYK
$150B
| $2.56B | 0.56% | 6,864,770 +22,699 | +0.3% | +$8.45M |
|
46
TransDigm Group
TDG
$78.8B
| $2.55B | 0.55% | 1,844,406 -66,722 | -3% | -$92.3M |
|
47
Mondelez International
MDLZ
$79.5B
| $2.43B | 0.53% | 35,830,140 -1,699,371 | -5% | -$115M |
|
48
Morgan Stanley
MS
$240B
| $2.33B | 0.51% | 19,962,428 -1,832,445 | -8% | -$214M |
|
49
American International
AIG
$45.1B
| $2.27B | 0.49% | 26,063,252 -8,827,562 | -25% | -$767M |
|
50
Freeport-McMoran
FCX
$63.7B
| $2.24B | 0.49% | 59,153,476 -18,159,607 | -23% | -$688M |
|